All News

Article

ACR21 Best Abstracts - Day 2

Jack Cush, MD

The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 2 (#ACRbest).

Dr. John Cush Tweet
RheumNow
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow and its Faculty.
Eric Dein Tweet
ericdeinmd
#ACR21 Rheum Pearls and Secrets Not all (or most) ulcers is Behcet's! Here's a great approach to use in clinic. Jason Kolfenbach: "Sometimes, taking off the mask is worth it" @Rheumnow https://t.co/OEBgf1eFhd
Eric Dein Tweet
ericdeinmd
#ACR21. Powerful patient perspective by Amy Barron, RN and rheumatic patient ⭐️"I found hope advocating for arthritis" and found meaning in advocacy. ▶️ Consider talking to your patients about getting involved in ACR Advocacy to give purpose & community. @ACRheumDC @CreakyJoints https://t.co/2mJRaShZQQ
Bella Mehta Tweet
bella_mehta
Oral Calcitonin not recommended for OA - studies did not show efficacy Strontium Ranelate study below was considered a positive study in KOA with efficacy but had Cardiovascular toxicity - now off the market. https://t.co/gcYH9xoxeo
Akhil Sood MD Tweet
AkhilSoodMD
Abst 0789 Baker & colleagues examined adipokine levels in association with disease activity in RA patients - Patients with high levels of adipokines less likely to achieve low disease activity & remission - These patients more likely to escalate to b/tsDMARDs #ACR21 @RheumNow https://t.co/1xlO4W9q9v
Akhil Sood MD Tweet
AkhilSoodMD
Another exciting day at #ACR21 and covering for @RheumNow Also presented my poster (Abstr 0587) DMARD Use in Medicare Patients with #RheumatoidArthritis and Risk of Long-Term Opioid Use - DMARD users showed lower odds of long term opioid use compared to non-DMARD users https://t.co/2XZgYY8ORg
Janet Pope Tweet
Janetbirdope
As old saying but updated goes: Wise man/woman/prefer not to answer says IF you STOP drugs they usually STOP working. True with TNFi in most diseases (RA, axSpA, etc). Also tue with #plaquenil in large #SLE study #ACR21 abst#0959 https://t.co/O6Ejg5sjjK
Pedro Castillo Tweet
_Castillo_Pedro
Stopping/reducing hydroxychloroquine (HCQ) in SLE associated with increased flares, especially for those in low disease activity or in remission. Super helpful data to share with pts wanting to reduce/dc HCQ. #ACR21 Abst#0959 Plenary Session II @RheumNow https://t.co/i7jPDN2sgZ
sheila Tweet
RHEUMarampa
Dr FCardwell et al on Health Info use in SLE pts b4 and during COVID19 using an online survey 🦋#lupus specialists & fam physicians - ⬆preferred & trusted health info sources but access to them ⬇frequent during covid19 A call to action?📢 @RheumNow #ACR21 abs0880 @rheumarhyme https://t.co/1NBEAlFvHx
David Liew Tweet
drdavidliew
We know we're all not as great at treat-to-target in RA as we should be. If we want to get fit, we join a group class. If we want to study, we join a study group. Why not the same with TTT, to motivate us to our best? Virtual learning collaboratives 👏 #ACR21 ABST0815 @RheumNow https://t.co/siVOyKjPNx
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×